comparemela.com

Phase 2 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phase 2 Trial Closure Clears a Path for Accelerated Development of Stenoparib in Ovarian Cancer

A phase 2 trial of stenoparib in advanced recurrent ovarian cancer has been closed early to enable a follow-on trial with FDA regulatory intent.

Thomas jensenAllarity therapeutics incAllarity therapeutics drug responseAllarity therapeuticsAccessed mayOvarian cancerFda regulatory intentTrial closurePhase 2 trial

A weight loss drug candidate could rival Ozempic

Viking Therapeutics reports strong results from phase 2 trial of a new anti-obesity drug, VK2735, showing potential to rival other GLP-1 drugs.

United statesEli lillyWashington postNovo nordiskViking therapeuticsPhase 2 trialGlp 1Anti obesity medicationsWeight lossEli lillyNovo nordisk

First Patient Dosed With Drug Combo in Phase 2 Gastric Cancer Trial

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.

United statesJennifer buellYelena janjigianGastrointestinal oncology serviceAmerican cancer societyMemorial sloan kettering cancer centerMink therapeuticsAmerican cancerChief gastrointestinal oncology serviceVitrakvi continuesImprove survivalSlower infusionAntiemetic drugs may help with nauseaGastric cancerAgent 797Phase 2 trial

Novel Drug Improves Survival in Advanced Brain Cancer

The novel drug BMX-001 showed improved survival in certain patients with high-grade glioma and reduced cognitive decline caused by radiation therapy.

Ines batinic haberleKatherineb petersDuke university school of medicineDuke university schoolPreston robert tisch brain tumor centerClinical trialsBrain cancerPhase 2 trial

Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2

Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.

Beth israel lahey healthMore such health newsClinical immunodeficiency programPharming groupDrug administrationPhase 2 trialPrimary immunodeficienciesHarming leniolisib

vimarsana © 2020. All Rights Reserved.